Yang Lijun, Zhao Hongshan, Li Shi-Wu, Ahrens Kim, Collins Christine, Eckenrode Sarah, Ruan Qing-guo, McIndoe Richard A, She Jin-Xiong
Department of Pathology, Immunology, and Laboratory Medicine, University of Florida College of Medicine, Gainesville, Florida 32610, USA.
J Mol Diagn. 2003 Nov;5(4):212-21. doi: 10.1016/S1525-1578(10)60476-X.
Using cDNA microarrays we determined the gene expression patterns in the human acute promyelocytic leukemia (APL) cell line NB4 during all-trans retinoic acid (ATRA)-induced differentiation. We analyzed the expression of 12,288 genes in the NB4 cells after 12 hours, 24 hours, 48 hours, 72 hours, and 96 hours of ATRA exposure. During this time course, we found 168 up-regulated and more than 179 down-regulated genes, most of which have not been reported before. Many of the altered genes encode products that participate in signaling pathways, cell differentiation, programmed cell death, transcription regulation, and production of cytokines and chemokines. Of interest, the CD52 and protein kinase A regulatory subunit alpha (PKA-Rlalpha) genes, whose products are being used as therapeutic targets for certain human neoplasias in currently ongoing clinical trials, were among the genes observed to be markedly up-regulated after ATRA treatment. The present study provides valuable data to further understand the mechanism of ATRA-induced APL cell differentiation and suggests potential therapeutic alternatives for this leukemia.
我们使用cDNA微阵列技术,确定了全反式维甲酸(ATRA)诱导分化过程中人类急性早幼粒细胞白血病(APL)细胞系NB4中的基因表达模式。我们分析了ATRA处理12小时、24小时、48小时、72小时和96小时后NB4细胞中12,288个基因的表达情况。在此时间进程中,我们发现了168个上调基因和179个以上的下调基因,其中大多数此前尚未见报道。许多变化的基因编码的产物参与信号通路、细胞分化、程序性细胞死亡、转录调控以及细胞因子和趋化因子的产生。有趣的是,CD52和蛋白激酶A调节亚基α(PKA-Rlα)基因的产物在当前正在进行的临床试验中被用作某些人类肿瘤的治疗靶点,它们在ATRA处理后被观察到显著上调。本研究提供了有价值的数据,以进一步了解ATRA诱导APL细胞分化的机制,并为这种白血病提出了潜在的治疗选择。